Miniatura

Fitxers

717891.pdf (973.34 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2021-12-29

Llicència de publicació

cc-by-nc-nd (c) Cruz González, Ignacio et al., 2021
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/182998

Impact of operatoŕs experience on peri-procedural outcomes with Watchman FLX: Insights from the FLX-SPA registry

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1016/j.ijcha.2021.100941

Resum

Background: The Watchman FLX is a device upgrade of the Watchman 2.5 that incorporates several design enhancements intended to simplify left atrial appendage occlusion (LAAO) and improve procedural outcomes. This study compares peri-procedural results of LAAO with Watchman FLX (Boston Scientific, Marlborough, Massachusetts) in centers with varying degrees of experience with the Watchman 2.5 and Watchman FLX. Methods: Prospective, multicenter, 'real-world' registry including consecutive patients undergoing LAAO with the Watchman FLX at 26 Spanish sites (FLX-SPA registry). Implanting centers were classified according to the center's prior experience with the Watchman 2.5. A further division of centers according to whether or not they had performed ≤ 10 or > 10Watchman FLX implants was prespecified at the beginning of the study. Procedural outcomes of institutions stratified according to their experience with the Watchman 2.5 and FLX devices were compared. Results: 359 patients [mean age 75.5 (SD8.1), CHA2DS2-VASc 4.4 (SD1.4), HAS-BLED 3.8(SD0.9)] were included. Global success rate was 98.6%, successful LAAO with the first selected device size was achieved in 95.5% patients and the device was implanted at first attempt in 78.6% cases. There were only 9(2.5%) major peri-procedural complications. No differences in efficacy or safety results according to the centeŕs previous experience with Watchman 2.5 and procedural volume with Watchman FLX existed. Conclusions: The Watchman FLX attains high procedural success rates with complete LAA sealing in unselected, real-world patients, along with a low incidence of peri-procedural complications, regardless of operatoŕs experience with its previous device iteration or the number of Watchman FLX devices implanted.

Matèries

Fibril·lació auricular, Implants artificials

Matèries (anglès)

Atrial fibrillation, Artificial implants

Citació

Col·leccions

Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

CRUZ GONZÁLEZ, Ignacio, TORRES SAURA, Francisco, TREJO VELASCO, Blanca, FERNÁNDEZ DÍAZ, José antonio, FAJARDO MOLINA, Ricardo, VALLE FERNÁNDEZ, Raquel del, MORENO TERRIBAS, Gerardo, MARTÍ SÁNCHEZ, David, LÓPEZ MÍNGUEZ, José ramón, GÓMEZ BLÁZQUEZ, Iván, SANMARTÍN PENA, Juan carlos, BOTAS, Javier, MARTÍN LORENZO, Pedro, PALAZUELOS, Jorge, ALBARRÁN RINCON, Ramón, MOHANDES, Mohsen, RODRÍGUEZ ENTEM, Felipe josé, MARTÍ, Gerard, VALERO, Ernesto, GUTIÉRREZ, Hipólito, AMAT SANTOS, Ignacio j., NOMBELA FRANCO, Luis, SALINAS, Pablo, TERUEL, Luis, GÓMEZ HOSPITAL, Joan antoni, ARZAMENDI, Dabit, TORRES SANABRIA, Mario, CALLE PÉREZ, Germán, CAÑADAS PRUAÑO, Dolores, PÉREZ DE PRADO, Armando, BENITO GONZÁLEZ, Tomás, ARROYO ÚCAR, Eduardo, ESTÉVEZ LOUREIRO, Rodrigo, CANEIRO QUEIJA, Berenice, IBAÑEZ CRIADO, José l., RUIZ NODAR, Juan m.. Impact of operatoŕs experience on peri-procedural outcomes with Watchman FLX: Insights from the FLX-SPA registry. _IJC Heart & Vasculature_. 2021. Vol. 38. [consulta: 23 de gener de 2026]. ISSN: 2352-9067. [Disponible a: https://hdl.handle.net/2445/182998]

Exportar metadades

JSON - METS

Compartir registre